Abiopharma

🔍 Sieffert Kristen N (Executive)

Company: Finance of America Companies Inc. (FOA)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 13,440 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 92,239.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,893 shares of Class A Common Stock at $16.6 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 87,346.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 41,667 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 129,013.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 14,946 shares of Class A Common Stock at $16.6 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 114,067.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 29,362 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 143,429.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 14,167 shares of Class A Common Stock at $16.6 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 129,262.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 750 shares of Class A Common Stock at $16.63 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 128,512.00 | transaction_form_type: 4 | Footnotes: F5, F6
• Sold 13,440 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 41,667 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 41,667.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3
• Sold 29,362 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 58,726.00 | transaction_form_type: 4 | Footnotes: F4, F4, F4
• Acquired 72,674 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 72,674.00 | transaction_form_type: 4 | Footnotes: F7, F7, F7

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock ("Common Stock"). The RSUs will be settled in either Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee.
• F2: Represents the withholding of shares of Common Stock for tax purposes in connection with the settlement of RSUs.
• F3: Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will be settled in either Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. The remaining RSUs vest on the third anniversary of April 1, 2024, subject to the Reporting Person's continued employment.
• F4: Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will be settled in either Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. The remaining RSUs vest on the second and third anniversaries of April 1, 2025, subject to the Reporting Person's continued employment.
• F5: Represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024.
• F6: These shares were sold in multiple transactions each at the price of $16.63.
• F7: Represents additional RSUs granted to the Reporting Person on April 1, 2026. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will be settled in either Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. The RSUs shall vest in one-third increments upon the first, second and third anniversaries of the vesting reference date, April 1, 2026, subject to the Reporting Person's continued employment.